SEC Form 4 · accession 0001179110-15-007573
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Schmertzler
Director
Period of report
May 7, 2015
Accepted (ET)
May 11, 2015 · 7:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF3 | May 7, 2015 | J | 1,125,722 | $0.00 | D | 4,569 | I | See footnote |
| Common StockF4,F5 | May 11, 2015 | J | 848 | — | D | 3,721 | I | See footnote |
| Common StockF1 | holding | — | — | — | 26,766 | D | ||
| Common StockF6 | holding | — | — | — | 1,320,369 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $51.00 | holding | — | — | — | Jan 2, 2016 | Jan 1, 2025 | Common Stock | 24,000 | 24,000 | D |
| Stock Option (Right to Buy) | $27.05 | holding | — | — | — | Jan 28, 2015 | Jan 27, 2024 | Common Stock | 20,000 | 20,000 | D |
| Stock Option (Right to Buy)F7 | $10.85 | holding | — | — | — | — | May 15, 2023 | Common Stock | 60,000 | 60,000 | D |
| Stock Option (Right to Buy)F8 | $218.40 | holding | — | — | — | — | Jan 10, 2022 | Common Stock | 276 | 276 | D |
| Stock Option (Right to Buy)F8 | $490.80 | holding | — | — | — | — | Apr 27, 2021 | Common Stock | 276 | 276 | D |
| Stock Option (Right to Buy)F8 | $1,149.60 | holding | — | — | — | — | Feb 2, 2020 | Common Stock | 216 | 216 | D |
| Stock Option (Right to Buy)F8 | $508.80 | holding | — | — | — | — | Oct 7, 2019 | Common Stock | 266 | 266 | D |
| Stock Option (Right to Buy)F8 | $735.60 | holding | — | — | — | — | Jan 25, 2018 | Common Stock | 166 | 166 | D |
| Stock Option (Right to Buy)F8 | $735.60 | holding | — | — | — | — | Jul 14, 2018 | Common Stock | 83 | 83 | D |
| Stock Option (Right to Buy)F8 | $626.40 | holding | — | — | — | — | Apr 18, 2017 | Common Stock | 125 | 125 | D |
| Stock Option (Right to Buy)F8 | $392.40 | holding | — | — | — | — | Mar 1, 2016 | Common Stock | 90 | 90 | D |
Explanation of responses
- F1Represents 26,766 shares of common stock of the Issuer ("common stock") directly held by the reporting person.
- F2Represents final distributions in kind, without consideration to the applicable limited partners, of common stock of the Issuer effected by Credit Suisse First Boston Equity Partners (Bermuda), L.P. (879,798 shares) and Credit Suisse First Boston Equity Partners, L.P. (245,924 shares). The shares of common stock distributed were initially received by these funds upon the automatic conversion of preferred stock at the time of the Issuer's initial public offering in June 2013. The reporting person is a managing director of Aries Advisors, LLC, the sub-advisor to Credit Suisse First Boston Equity Partners, L.P. The reporting person disclaims beneficial ownership of the distributed shares of common stock except to the extent of his pecuniary interest therein.
- F3Consists of (i) 3,487 shares of common stock held by EMA Private Equity Fund 1999 LP; (ii) 848 shares of common stock held by Credit Suisse First Boston U S Executive Advisors LP; and (iii) 234 shares of common stock held by Credit Suisse First Boston Finders and Screeners LP. The reporting person disclaims beneficial ownership of the shares of common stock held by these entities.
- F4Represents dispositions pursuant to Rule 144 of 848 shares of common stock at a weighted average price of $55.6807 per share by Credit Suisse First Boston U S Executive Advisors LP. Although included in the reporting person's prior ownership reports, the reporting person disclaims beneficial ownership of the disposed securities.
- F5Consists of (i) 3,487 shares of common stock held by EMA Private Equity Fund 1999 LP; and (ii) 234 shares of common stock held by Credit Suisse First Boston Finders and Screeners LP. The reporting person disclaims beneficial ownership of the shares of common stock held by these entities.
- F6Represents shares of common stock held by Section Six Partners, L.P. The reporting person is a general and limited partner of, and trustee of certain family trusts holding interests in, Section Six Partners, L.P. The reporting person disclaims beneficial ownership of the shares of common stock held by Section Six Partners, L.P. except to the extent of his pecuniary interest therein.
- F7This option was granted on May 15, 2013 and vests over three years, with 8.33% of the shares underlying the option vested on August 15, 2013 and an additional 8.33% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter.
- F8Currently exercisable.